Molecular diagnostics company Co-Diagnostics Inc (Nasdaq:CODX) stated on Friday that Australia has authorized the use of is Logix Smart COVID-19 for detecting SARS-CoV-2, the virus that causes COVID-19, following the receipt of The Australian Government Register of Therapeutic Goods Certificate.

The certificate allows the company's distributor to supply the Class 3 IVD to the Australian market. Australia joins the US, India, Mexico, the European Community and others as a region where the Logix Smart test can be sold and used as a coronavirus in vitro diagnostic (IVD).

Currently, the company's CE-marked and FDA EUA Co-Diagnostics Logix Smart COVID-19 test is available to all clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) and is authorized to be used for the diagnosis of SARS-CoV-2 in the US and other countries.

.

(C) 2020 M2 COMMUNICATIONS, source M2 PressWIRE